Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
74.1M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
56.7M
-
Shares change
-
+1.55M
-
Total reported value, excl. options
-
$513M
-
Value change
-
+$19.9M
-
Put/Call ratio
-
0.35
-
Number of buys
-
77
-
Number of sells
-
-42
-
Price
-
$9.04
Significant Holders of Zymeworks Inc. - Common Stock, par value $0.00001 per share (ZYME) as of Q1 2023
137 filings reported holding ZYME - Zymeworks Inc. - Common Stock, par value $0.00001 per share as of Q1 2023.
Zymeworks Inc. - Common Stock, par value $0.00001 per share (ZYME) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.7M shares
of 74.1M outstanding shares and own 76.51% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (10.1M shares), Redmile Group, LLC (6.07M shares), BVF INC/IL (5.87M shares), MORGAN STANLEY (5.56M shares), PERCEPTIVE ADVISORS LLC (3.38M shares), Rubric Capital Management LP (2.85M shares), CREDIT SUISSE AG/ (2.49M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (2.31M shares), VANGUARD GROUP INC (2.04M shares), and FARALLON CAPITAL MANAGEMENT LLC (2M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.